Eli Lilly shows strong trial results, with shares trading at $839.96

Novo Nordisk's Wegovy continues to lead in obesity treatment; stock at $58.08

Vertex Pharmaceuticals advances gene-editing therapies; stock is $489.10

Intuitive Surgical's Da Vinci system enhances surgical precision; stock at $482.74

UnitedHealth Group is trading at $454.11, the stock is undervalued, making it a good long-term stock in 2025

Gilead Sciences maintains a strong market position, stock trading at $104.54